enGene Holdings Inc. Common Stock
Stock Chart, Company Information, and Scan Results
$9.45(as of Dec 24, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
enGene Holdings Inc. Common Stock Company Information, Fundamentals, and Technical Indicators
Stock Price$9.45
Ticker SymbolENGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees56
CountyUSA
Market Cap$633.0M
EBIDTA-122.7M
P/E Ratio-7.38
Forward P/E Ratio0.00
Earnings per Share-2.29
Profit Margin-Infinity%
RSI63.53
Shares Outstanding67.0M
ATR0.78
52-Week High11.14
Volume583,997
52-Week Low2.75
Book Value167.7M
P/B Ratio2.89
Upper Keltner10.12
P/S RatioInfinity
Lower Keltner6.59
Debt-to-Equity Ratio10.12
Next Earnings DateUnknown
Cash Surplus18.2M
Next Ex-Dividend DateUnknown
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.
enGene Holdings Inc. Common Stock In Our Stock Scanner
As of Dec 26, 2025
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.